Contact this trialFirst, we need to learn more about you.
CDK4 Inhibitor
BGB-43395 Combinations for Breast Cancer
Recruiting1 awardPhase 1
Columbus, Ohio
This trial is testing a new drug called BGB-43395 to see how well it works on its own or when combined with other drugs in participants with hormone receptor positive and human epidermal growth
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service